The FDA has received reports of acute pancreatitis in patients using semaglutide and tirzepatide, though causality remains uncertain and incidence rates remain low
They're looking for nuances and details that a questionnaire can't capture
Xue X, Ren Z, Zhang A, Yang Q, Zhang W, Liu F (2016) Efficacy and safety of once-weekly glucagon-like peptide-1 receptor agonists compared with exenatide and liraglutide in type 2 diabetes: a systemic review of randomised controlled trials
Data of most crystals were limited to 10 because of radiation damage and only two crystals were collected to 180
For a deeper look at this relationship, see our guide on gut microbiome, circadian rhythm, and metabolic balance
Abstract Diabetic Kidney Disease (DKD) is the leading cause of end stage renal disease (ESRD) worldwide